Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q1 2026 (March 31)3holders +1
1new positions
0sold out
$1.48avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.7M), Ssi Investment Management LLC ($450K) and Bank of New York Mellon Corp ($292K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $450K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 308,000 shares bought and 650,000 shares sold, net −342,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Reduce -20.6% | 2,500,000 | $3.7M |
| Ssi Investment Management LLC | 0.04% | New | 308,000 | $450K |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $292K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.